Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study
- Autores
- Ciapponi, Agustín; Virgilio, Sacha Alexis; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Álvaro; Rojas Illanes, Moisés Freddy; Rubio Martinez, Briseida; Gamba, Johana; González Salazar, Carlos Arturo; Rocha Rodríguez, José Nicolás; Scarpellini, Bruno; Bravo Perdomo, Ana María; Machnicki, Gerardo; Aldunate, Leandro; De Paula, Juan; Bardach, Ariel Esteban
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background and aims Ulcerative Colitis (UC) and Crohn’s Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. Methods We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. Results The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. Conclusions The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition.
Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Virgilio, Sacha Alexis. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Claire Soto, Natalie. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Ciganda, Álvaro. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Rojas Illanes, Moisés Freddy. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Rubio Martinez, Briseida. Hospital Dr. Bernardo Sepúlveda; México
Fil: Gamba, Johana. Fundación Universitaria Sanitas; Colombia
Fil: González Salazar, Carlos Arturo. Fundación Universitaria Sanitas; Colombia
Fil: Rocha Rodríguez, José Nicolás. Fundación Universitaria Sanitas; Colombia
Fil: Scarpellini, Bruno. No especifíca;
Fil: Bravo Perdomo, Ana María. No especifíca;
Fil: Machnicki, Gerardo. No especifíca;
Fil: Aldunate, Leandro. No especifíca;
Fil: De Paula, Juan. Hospital Italiano; Argentina
Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina - Materia
-
Epidemiology
Mathematical modelling
Mexico
Colombia - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/142512
Ver los metadatos del registro completo
id |
CONICETDig_748e0d7f4ccc439c86441127c5bfd418 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/142512 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series studyCiapponi, AgustínVirgilio, Sacha AlexisBerrueta, MabelClaire Soto, NatalieCiganda, ÁlvaroRojas Illanes, Moisés FreddyRubio Martinez, BriseidaGamba, JohanaGonzález Salazar, Carlos ArturoRocha Rodríguez, José NicolásScarpellini, BrunoBravo Perdomo, Ana MaríaMachnicki, GerardoAldunate, LeandroDe Paula, JuanBardach, Ariel EstebanEpidemiologyMathematical modellingMexicoColombiahttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background and aims Ulcerative Colitis (UC) and Crohn’s Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. Methods We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. Results The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. Conclusions The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition.Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Virgilio, Sacha Alexis. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Claire Soto, Natalie. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Ciganda, Álvaro. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Rojas Illanes, Moisés Freddy. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Rubio Martinez, Briseida. Hospital Dr. Bernardo Sepúlveda; MéxicoFil: Gamba, Johana. Fundación Universitaria Sanitas; ColombiaFil: González Salazar, Carlos Arturo. Fundación Universitaria Sanitas; ColombiaFil: Rocha Rodríguez, José Nicolás. Fundación Universitaria Sanitas; ColombiaFil: Scarpellini, Bruno. No especifíca;Fil: Bravo Perdomo, Ana María. No especifíca;Fil: Machnicki, Gerardo. No especifíca;Fil: Aldunate, Leandro. No especifíca;Fil: De Paula, Juan. Hospital Italiano; ArgentinaFil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaPublic Library of Science2020-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/142512Ciapponi, Agustín; Virgilio, Sacha Alexis; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Álvaro; et al.; Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study; Public Library of Science; Plos One; 15; 1; 1-2020; 1-171932-6203CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://dx.plos.org/10.1371/journal.pone.0228256info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0228256info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:18:09Zoai:ri.conicet.gov.ar:11336/142512instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:18:09.456CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
title |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
spellingShingle |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study Ciapponi, Agustín Epidemiology Mathematical modelling Mexico Colombia |
title_short |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
title_full |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
title_fullStr |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
title_full_unstemmed |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
title_sort |
Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study |
dc.creator.none.fl_str_mv |
Ciapponi, Agustín Virgilio, Sacha Alexis Berrueta, Mabel Claire Soto, Natalie Ciganda, Álvaro Rojas Illanes, Moisés Freddy Rubio Martinez, Briseida Gamba, Johana González Salazar, Carlos Arturo Rocha Rodríguez, José Nicolás Scarpellini, Bruno Bravo Perdomo, Ana María Machnicki, Gerardo Aldunate, Leandro De Paula, Juan Bardach, Ariel Esteban |
author |
Ciapponi, Agustín |
author_facet |
Ciapponi, Agustín Virgilio, Sacha Alexis Berrueta, Mabel Claire Soto, Natalie Ciganda, Álvaro Rojas Illanes, Moisés Freddy Rubio Martinez, Briseida Gamba, Johana González Salazar, Carlos Arturo Rocha Rodríguez, José Nicolás Scarpellini, Bruno Bravo Perdomo, Ana María Machnicki, Gerardo Aldunate, Leandro De Paula, Juan Bardach, Ariel Esteban |
author_role |
author |
author2 |
Virgilio, Sacha Alexis Berrueta, Mabel Claire Soto, Natalie Ciganda, Álvaro Rojas Illanes, Moisés Freddy Rubio Martinez, Briseida Gamba, Johana González Salazar, Carlos Arturo Rocha Rodríguez, José Nicolás Scarpellini, Bruno Bravo Perdomo, Ana María Machnicki, Gerardo Aldunate, Leandro De Paula, Juan Bardach, Ariel Esteban |
author2_role |
author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Epidemiology Mathematical modelling Mexico Colombia |
topic |
Epidemiology Mathematical modelling Mexico Colombia |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background and aims Ulcerative Colitis (UC) and Crohn’s Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. Methods We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. Results The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. Conclusions The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition. Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina Fil: Virgilio, Sacha Alexis. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Claire Soto, Natalie. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Ciganda, Álvaro. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Rojas Illanes, Moisés Freddy. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Rubio Martinez, Briseida. Hospital Dr. Bernardo Sepúlveda; México Fil: Gamba, Johana. Fundación Universitaria Sanitas; Colombia Fil: González Salazar, Carlos Arturo. Fundación Universitaria Sanitas; Colombia Fil: Rocha Rodríguez, José Nicolás. Fundación Universitaria Sanitas; Colombia Fil: Scarpellini, Bruno. No especifíca; Fil: Bravo Perdomo, Ana María. No especifíca; Fil: Machnicki, Gerardo. No especifíca; Fil: Aldunate, Leandro. No especifíca; Fil: De Paula, Juan. Hospital Italiano; Argentina Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina |
description |
Background and aims Ulcerative Colitis (UC) and Crohn’s Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. Methods We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. Results The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. Conclusions The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/142512 Ciapponi, Agustín; Virgilio, Sacha Alexis; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Álvaro; et al.; Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study; Public Library of Science; Plos One; 15; 1; 1-2020; 1-17 1932-6203 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/142512 |
identifier_str_mv |
Ciapponi, Agustín; Virgilio, Sacha Alexis; Berrueta, Mabel; Claire Soto, Natalie; Ciganda, Álvaro; et al.; Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study; Public Library of Science; Plos One; 15; 1; 1-2020; 1-17 1932-6203 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://dx.plos.org/10.1371/journal.pone.0228256 info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0228256 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Public Library of Science |
publisher.none.fl_str_mv |
Public Library of Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614140764618752 |
score |
13.070432 |